CompletedPhase 2NCT03714828
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
Studying Muir-Torre syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Arizona
- Principal Investigator
- Clara Curiel, MD, MDUniversity of Arizona
- Intervention
- Injection of TVEC into target lesions - week 1-2(drug)
- Enrollment
- 11 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2023
Study locations (2)
- Honor Health Research Institute, Scottsdale, Arizona, United States
- University of Arizona Cancer Center, Tucson, Arizona, United States
Collaborators
Amgen
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03714828 on ClinicalTrials.gov